Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
19.53 USD | +8.62% | +25.56% | +30.61% |
05-02 | NovoCure Shares Steady After Reporting Narrower Q1 Loss, Higher Revenue | MT |
05-02 | BioPharma Credit Enters $400 Million Loan Agreement with Novocure Luxembourg | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.61% | 1.93B | |
+73.46% | 12.4B | |
-16.49% | 7.94B | |
+0.06% | 6.17B | |
+15.76% | 5.55B | |
-3.52% | 5.35B | |
+46.20% | 5.03B | |
-17.73% | 4.07B | |
-28.80% | 2.65B | |
-0.99% | 1.99B |
- Stock Market
- Equities
- NVCR Stock
- News NovoCure Limited
- Transcript : NovoCure Limited - Shareholder/Analyst Call